Heba Jalil

Provisional Text Of The Political Agreement On The Reform To The EU Regulatory Framework For Medicinal Products Is Published

Can A Chemically Synthesised Medicine Be Authorised As A Generic Of A Biological Medicine? And Who Can Challenge This?

Updates To The EU Pharmacovigilance Rules: Key Takeaways For Marketing Authorisation Holders

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

An Update From The European Court Of Justice On Discount Campaigns Run By Mail Order Pharmacies

UK Public Procurement Landscape Transformed: What Does It Mean For Medicines?

UK To Implement Novel Framework For Point-Of-Care Manufacturing

Virtual And Digital Health Digest, March 2024

Virtual And Digital Health Digest: February